Physician profile
David S Fortune
NPI 1245274778
$298,283.82
in general payments reported to CMS, 2019-2025
26 companies · $56K in 2025
The $56K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90K · 2020: $19K · 2021: $17K · 2022: $37K · 2023: $43K · 2024: $36K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $106K · Travel and Lodging: $18K · Food and Beverage: $6,541 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,950 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $106,118.45 |
| Travel and Lodging | $18,289.99 |
| Food and Beverage | $6,540.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,950.00 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $190,123.91 | 2019-2025 | Xpress Ent Dilation System, Scopis Ent, Tgs Guidewire |
| Aerin Medical INC. | $66,418.44 | 2019-2025 | |
| Acclarent, INC | $16,885.12 | 2021-2024 | Acclarent Balloon Inflation Device, Acclarent Aera, Acclarent Navwire |
| Integra Lifesciences Corporation | $14,353.76 | 2022-2025 | Acclarent Aera, Inspira Air, Integra |
| Smith+Nephew, INC. | $7,398.15 | 2019-2025 | Coblation, Halo, Tula |
| Genzyme Corporation | $624.45 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $498.06 | 2019-2025 | Dupixent |
| Glaxosmithkline, LLC. | $355.33 | 2019-2025 | Nucala |
| Medtronic, INC. | $336.52 | 2021-2024 | Propel |
| Intersect Ent, INC. | $240.41 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $173.19 | 2019-2025 | |
| Inspire Medical Systems, INC. | $169.12 | 2025 | Inspire |
| Optinose US, INC. | $144.01 | 2020-2025 | |
| Genentech USA, INC. | $131.07 | 2019-2025 | Xolair |
| Kaleo, INC. | $106.24 | 2019-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $86.23 | 2019-2025 | Fasenra, Tezspire |
| Alk-Abello, INC | $43.31 | 2021-2025 | Alternaria Tenuis, Pre-Pen, Standardized Mite D. Farinae |
| Amgen INC. | $34.00 | 2025 | |
| Neurent Medical Limited | $24.26 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Pfizer INC. | $22.60 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $21.95 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $21.40 | 2023 | Coolseal Generator |
| Paratek Pharmaceuticals, INC. | $19.39 | 2025 | Nuzyra |
| Baxter Healthcare | $19.26 | 2025 | Perclot |
| Hikma Pharmaceuticals USA | $17.64 | 2025 | Ryaltris |
| Phadia US INC. | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fortune listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.